The journal retracts the article, “Actively Targeted Nanodelivery of Echinomycin Induces Autophagy-Mediated Death in Chemoresistant Pancreatic Cancer In Vivo” [1], cited above.
Following publication, concerns were brought to the attention of the Editorial Office regarding multiple irregularities found in images presented in this article [1].
Adhering to our standard procedure, an investigation was conducted by the Editorial Office and Editorial Board, which confirmed indications of inappropriate image editing contained within Figures 3A and 6C. While the authors fully collaborated with this process, they were unable to provide supporting material for the Editorial Board evaluation. As a result, the Editorial Board has lost confidence in the reliability of the findings and decided to retract this publication [1], as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30).
This retraction was approved by the Editor-in-Chief of the journal Cancers journal.
The authors did not agree to this retraction.
Reference
- Thomas, A.; Samykutty, A.; Gomez-Gutierrez, J.G.; Yin, W.; Egger, M.E.; McNally, M.; Chuong, P.; MacCuaig, W.M.; Albeituni, S.; Zeiderman, M.; et al. RETRACTED: Actively Targeted Nanodelivery of Echinomycin Induces Autophagy-Mediated Death in Chemoresistant Pancreatic Cancer In Vivo. Cancers 2020, 12, 2279. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).